Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Update

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the recipient of a large decline in short interest in November. As of November 15th, there was short interest totalling 234,100 shares, a decline of 37.4% from the October 31st total of 374,100 shares. Approximately 11.7% of the shares of the company are sold short. Based on an average daily trading volume, of 612,800 shares, the short-interest ratio is currently 0.4 days.

Sunshine Biopharma Trading Down 10.2 %

Sunshine Biopharma stock traded down $0.31 during midday trading on Thursday, hitting $2.73. The stock had a trading volume of 552,331 shares, compared to its average volume of 254,545. Sunshine Biopharma has a 52-week low of $2.11 and a 52-week high of $608.00. The company has a market capitalization of $3.33 million, a PE ratio of -0.02 and a beta of 1.38. The firm’s fifty day moving average is $2.86 and its two-hundred day moving average is $1.81.

Sunshine Biopharma (NASDAQ:SBFM) last announced its quarterly earnings data on Tuesday, November 5th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94). Sunshine Biopharma had a negative return on equity of 17.89% and a negative net margin of 12.82%. The firm had revenue of $8.44 million during the quarter.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.